These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26032400)

  • 21. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I; Rüster C; Franke S; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2013 Sep; 305(6):F911-8. PubMed ID: 23825071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity.
    Bondeva T; Wolf G
    Am J Nephrol; 2009; 30(4):336-45. PubMed ID: 19590177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of podocyte p130Cas in diabetic conditions.
    Ha TS; Choi JY; Park HY; Han GD
    J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
    Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of CD2-associated protein influences podocyte endoplasmic reticulum stress-mediated apoptosis induced by albumin overload.
    He F; Chen S; Wang H; Shao N; Tian X; Jiang H; Liu J; Zhu Z; Meng X; Zhang C
    Gene; 2011 Sep; 484(1-2):18-25. PubMed ID: 21679752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.
    Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F
    Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qiwei granules alleviates podocyte lesion in kidney of diabetic KK-Ay mice.
    Zhou J; Sun W; Yoshitomi H; Li L; Qin L; Guo X; Wu L; Zhang Y; Wu X; Xu T; Gao M; Liu T
    BMC Complement Altern Med; 2015 Mar; 15():97. PubMed ID: 25887645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
    Zhang L; Zhang Q; Liu S; Chen Y; Li R; Lin T; Yu C; Zhang H; Huang Z; Zhao X; Tan X; Li Z; Ye Z; Ma J; Zhang B; Wang W; Shi W; Liang X
    Kidney Int; 2017 Jul; 92(1):140-153. PubMed ID: 28318634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.
    Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA
    J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility.
    Ivanova EA; Arcolino FO; Elmonem MA; Rastaldi MP; Giardino L; Cornelissen EM; van den Heuvel LP; Levtchenko EN
    Kidney Int; 2016 May; 89(5):1037-1048. PubMed ID: 27083281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy.
    Kumar PA; Kotlyarevska K; Dejkhmaron P; Reddy GR; Lu C; Bhojani MS; Menon RK
    J Biol Chem; 2010 Oct; 285(41):31148-56. PubMed ID: 20682777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.
    Sohn E; Kim J; Kim CS; Jo K; Kim JS
    Mol Med Rep; 2015 Oct; 12(4):5837-45. PubMed ID: 26299942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end products impair protein turnover in LLC-PK1: amelioration by trypsin.
    Xiang G; Schinzel R; Simm A; Sebekova K; Heidland A
    Kidney Int Suppl; 2001 Feb; 78():S53-7. PubMed ID: 11168983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan inhibits AGE-induced podocyte damage and detachment.
    Fukami K; Yamagishi S; Kaifu K; Matsui T; Kaida Y; Ueda S; Takeuchi M; Asanuma K; Okuda S
    Microvasc Res; 2013 Jul; 88():79-83. PubMed ID: 23648312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
    Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
    J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin promotes podocyte migration through the up-regulation of urokinase receptor.
    Wu MJ; Chang CH; Shu KH; Ho HC; Li JR; Fu YC
    Transplant Proc; 2014 May; 46(4):1226-8. PubMed ID: 24815166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.